Skip to main content
Erschienen in: Inflammation 1/2013

01.02.2013

Downregulation of CCR5 Expression on the Peripheral Blood CD8+ T Cells of Southeastern Iranian Patients with Chronic Hepatitis B Infection

verfasst von: Behzad Nasiri Ahmadabadi, Gholamhossein Hassanshahi, Hossein Khoramdelazad, Vahid Mirzaei, Seyed Mohammad Ali Sajadi, Masomeh Hajghani, Hassan Khodadadi, Reza Pourali, Mohammad Kazemi Arababadi, Derek Kennedy

Erschienen in: Inflammation | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Studies indicated that CC receptor 5 (CCR5), as a receptor for CC ligand 3, CCL4, and CCL5, plays important roles in the recruitment of T cytotoxic lymphocytes to the liver of chronic HBV (CHB)-infected patients. The main purpose of this study was to investigate the expression levels of CCR5 on the CD8+ T lymphocytes of CHB patients. This clinical study was performed on 63 CHB patients and 96 healthy controls. Flow cytometric analysis was performed to examine the expression of CCR5 on CD8+ T cells of CHB patients. Real-time PCR was also used for HBV-DNA quantification. The results of our study demonstrated that CCR5 expressing T cytotoxic cells were decreased significantly in CHB patients in comparison to healthy control. Based on our results, it can be concluded that the percent of CCR5+/CD8+ T cells in Iranian CHB patients is significantly decreased, hence their migration to the infected liver, and HBV eradication from the hepatocytes is disrupted.
Literatur
1.
Zurück zum Zitat Assar S, Arababadi MK, Mohit M, et al. 2012 T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: A study from the south-eastern region of Iran. Clin Lab. Article in press. Assar S, Arababadi MK, Mohit M, et al. 2012 T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: A study from the south-eastern region of Iran. Clin Lab. Article in press.
2.
Zurück zum Zitat Ahn, S.H., D.Y. Kim, H.Y. Chang, et al. 2006. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. Journal of Medical Virology 78: 1564–1571.PubMedCrossRef Ahn, S.H., D.Y. Kim, H.Y. Chang, et al. 2006. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. Journal of Medical Virology 78: 1564–1571.PubMedCrossRef
3.
Zurück zum Zitat Herceg, Z., and A. Paliwal. 2011. Epigenetic mechanisms in hepatocellular carcinoma: Ow environmental factors influence the epigenome. Mutation Research 727: 55–61.PubMedCrossRef Herceg, Z., and A. Paliwal. 2011. Epigenetic mechanisms in hepatocellular carcinoma: Ow environmental factors influence the epigenome. Mutation Research 727: 55–61.PubMedCrossRef
4.
Zurück zum Zitat Arababadi, M.K., A.A. Pourfathollah, A. Jafarzadeh, et al. 2010. Decreased expression of CCR5 on the NK cells in occult HBV infected patients. Laboratory Medicine 41: 735–738.CrossRef Arababadi, M.K., A.A. Pourfathollah, A. Jafarzadeh, et al. 2010. Decreased expression of CCR5 on the NK cells in occult HBV infected patients. Laboratory Medicine 41: 735–738.CrossRef
5.
Zurück zum Zitat Arababadi, M.K., A.A. Pourfathollah, A. Jafarzadeh, et al. 2010. Peripheral blood CD8+ T cells CCR5 expression and its ∆32 mutation in Iranian patients with occult hepatitis B infection. Laboratory Medicine 41: 226–230.CrossRef Arababadi, M.K., A.A. Pourfathollah, A. Jafarzadeh, et al. 2010. Peripheral blood CD8+ T cells CCR5 expression and its ∆32 mutation in Iranian patients with occult hepatitis B infection. Laboratory Medicine 41: 226–230.CrossRef
6.
Zurück zum Zitat Crane, I.J., H. Xu, C. Wallace, et al. 2006. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. Journal of Leukocyte Biology 79: 435–443.PubMedCrossRef Crane, I.J., H. Xu, C. Wallace, et al. 2006. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. Journal of Leukocyte Biology 79: 435–443.PubMedCrossRef
7.
Zurück zum Zitat Khan, I.A., S.Y. Thomas, M.M. Moretto, et al. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathogens 2: e49.PubMedCrossRef Khan, I.A., S.Y. Thomas, M.M. Moretto, et al. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathogens 2: e49.PubMedCrossRef
8.
Zurück zum Zitat Ajuebor, M.N., J.A. Carey, and M.G. Swain. 2006. CCR5 in T cell-mediated liver diseases: What's going on? Journal of Immunology 177: 2039–2045. Ajuebor, M.N., J.A. Carey, and M.G. Swain. 2006. CCR5 in T cell-mediated liver diseases: What's going on? Journal of Immunology 177: 2039–2045.
9.
Zurück zum Zitat Fisicaro, P., C. Valdatta, C. Boni, et al. 2009. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58: 974–982.PubMedCrossRef Fisicaro, P., C. Valdatta, C. Boni, et al. 2009. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58: 974–982.PubMedCrossRef
10.
Zurück zum Zitat Rahbar, R., T.T. Murooka, and E.N. Fish. 2009. Role for CCR5 in dissemination of vaccinia virus in vivo. Journal of Virology 83: 2226–2236.PubMedCrossRef Rahbar, R., T.T. Murooka, and E.N. Fish. 2009. Role for CCR5 in dissemination of vaccinia virus in vivo. Journal of Virology 83: 2226–2236.PubMedCrossRef
11.
Zurück zum Zitat Liu, H.G., W.W. Chen, Z.P. Fan, et al. 2007. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. Clinical Immunology 125: 337–345.PubMedCrossRef Liu, H.G., W.W. Chen, Z.P. Fan, et al. 2007. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. Clinical Immunology 125: 337–345.PubMedCrossRef
12.
Zurück zum Zitat Lee, C.K., J.H. Suh, Y.S. Cho, et al. 2002. Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection. Taehan Kan Hakhoe Chi 8: 363–370.PubMed Lee, C.K., J.H. Suh, Y.S. Cho, et al. 2002. Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection. Taehan Kan Hakhoe Chi 8: 363–370.PubMed
13.
Zurück zum Zitat Shimada, N., K. Yamamoto, M.J. Kuroda, et al. 2003. HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. Journal of Clinical Immunology 23: 223–232.PubMedCrossRef Shimada, N., K. Yamamoto, M.J. Kuroda, et al. 2003. HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. Journal of Clinical Immunology 23: 223–232.PubMedCrossRef
14.
Zurück zum Zitat TrehanPati, N., and R. Geffers. 2009. Sukriti, et al. Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection. Hepatology 49: 781–790.PubMedCrossRef TrehanPati, N., and R. Geffers. 2009. Sukriti, et al. Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection. Hepatology 49: 781–790.PubMedCrossRef
15.
Zurück zum Zitat Suneetha, P.V., S.K. Sarin, A. Goyal, et al. 2006. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. Journal of Hepatology 44: 856–863.PubMedCrossRef Suneetha, P.V., S.K. Sarin, A. Goyal, et al. 2006. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. Journal of Hepatology 44: 856–863.PubMedCrossRef
16.
Zurück zum Zitat Chen, D.Q., Y. Zeng, J. Zhou, et al. 2010. Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. Journal of Medical Virology 82: 371–378.PubMedCrossRef Chen, D.Q., Y. Zeng, J. Zhou, et al. 2010. Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. Journal of Medical Virology 82: 371–378.PubMedCrossRef
17.
Zurück zum Zitat Chang, H.Y., S.H. Ahn, D.Y. Kim, et al. 2005. Association between CCR5 promoter polymorphisms and hepatitis B virus infection. The Korean Journal of Hepatology 11: 116–124.PubMed Chang, H.Y., S.H. Ahn, D.Y. Kim, et al. 2005. Association between CCR5 promoter polymorphisms and hepatitis B virus infection. The Korean Journal of Hepatology 11: 116–124.PubMed
18.
Zurück zum Zitat Arababadi, M.K., G. Hassanshahi, H. Azin, et al. 2010. No association between CCR5-∆32 mutation and multiple sclerosis in patients of south-eastern of Iran. Laboratory Medicine 41: 31–33.CrossRef Arababadi, M.K., G. Hassanshahi, H. Azin, et al. 2010. No association between CCR5-∆32 mutation and multiple sclerosis in patients of south-eastern of Iran. Laboratory Medicine 41: 31–33.CrossRef
19.
Zurück zum Zitat Arababadi, M.K., N. Naghavi, G. Hassanshahi, et al. 2009. Is CCR5-delta32 mutation associated with diabetic nephropathy in type 2 diabetes? Annals of Saudi Medicine 29: 413.PubMedCrossRef Arababadi, M.K., N. Naghavi, G. Hassanshahi, et al. 2009. Is CCR5-delta32 mutation associated with diabetic nephropathy in type 2 diabetes? Annals of Saudi Medicine 29: 413.PubMedCrossRef
Metadaten
Titel
Downregulation of CCR5 Expression on the Peripheral Blood CD8+ T Cells of Southeastern Iranian Patients with Chronic Hepatitis B Infection
verfasst von
Behzad Nasiri Ahmadabadi
Gholamhossein Hassanshahi
Hossein Khoramdelazad
Vahid Mirzaei
Seyed Mohammad Ali Sajadi
Masomeh Hajghani
Hassan Khodadadi
Reza Pourali
Mohammad Kazemi Arababadi
Derek Kennedy
Publikationsdatum
01.02.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9528-4

Weitere Artikel der Ausgabe 1/2013

Inflammation 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.